John C Byrd

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Atrial Fibrillation

Tyrosine Kinase

Chronic Lymphocytic Leukemia

Top Venues

Cancer discovery

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

John Alan Gambril, Sanam M Ghazi, Stephen Sansoterra, Mussammat Ferdousi, Onaopepo Kola-Kehinde, Patrick Ruz, Adam S Kittai, Kerry Rogers, Michael R Grever, Seema Bhat, Tracy Wiczer, John C Byrd, Jennifer A Woyach, Daniel Addison
Atrial fibrillation burden and clinical outcomes following BTK inhibitor initiation. Leukemia (2024)
Jennifer A Woyach, Deborah M Stephens, Ian W Flinn, Seema A Bhat, Ronald E Savage, Feng Chai, Sudharshan Eathiraj, Sean D Reiff, Elizabeth M Muhowski, Lindsey Granlund, Lyndsey Szuszkiewicz, Wayne Wang, Brian Schwartz, Razi Ghori, Mohammed Z H Farooqui, John C Byrd
First in Human Study of the Reversible BTK Inhibitor Nemtabrutinib in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia and B-Cell Non-Hodgkin Lymphoma. Cancer discovery (2023)
Jennifer A Woyach, Paolo Ghia, John C Byrd, Inhye E Ahn, Carol Moreno, Susan M O'Brien, Daniel M Jones, Leo W K Cheung, Elizabeth Chong, Kevin Kwei, James P Dean, Danelle F James, Adrian Wiestner
B-cell receptor pathway mutations are infrequent in patients with chronic lymphocytic leukemia on continuous ibrutinib therapy. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Anna H Yeaton, Geraldine Cayanan, Sanam Loghavi, Igor Dolgalev, Emmett M Leddin, Christian E Loo, Hedieh Torabifard, Deedra Nicolet, Jingjing Wang, Kate Corrigan, Varvara Paraskevopoulou, Daniel T Starczynowski, Eric Wang, Omar Abdel-Wahab, Aaron D Viny, Richard M Stone, John C Byrd, Olga A Guryanova, Rahul M Kohli, Gerardo Andrés Cisneros, Aristotelis Tsirigos, Ann-Kathrin Eisfeld, Iannis Aifantis, Maria Guillamot
The Impact of Inflammation-Induced Tumor Plasticity during Myeloid Transformation. Cancer discovery 12 (10) (2022)
Jonathan Mitry Hyak, Ying Huang, Kerry A Rogers, Seema A Bhat, Michael R Grever, John C Byrd, Adam S Kittai, Daniel M Jones, Cecelia R Miller, Jennifer A Woyach
Combined BCL2 and BTK inhibition in CLL demonstrates efficacy after monotherapy with both classes. Blood advances 6 (17) (2022)